123 related articles for article (PubMed ID: 30636011)
41. Extrahepatic metastases of hepatocellular carcinoma.
Katyal S; Oliver JH; Peterson MS; Ferris JV; Carr BS; Baron RL
Radiology; 2000 Sep; 216(3):698-703. PubMed ID: 10966697
[TBL] [Abstract][Full Text] [Related]
42. FRZB up-regulated in hepatocellular carcinoma bone metastasis.
Huang J; Hu W; Lin X; Wang X; Jin K
Int J Clin Exp Pathol; 2015; 8(10):13353-9. PubMed ID: 26722540
[TBL] [Abstract][Full Text] [Related]
43. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
44. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
45. The spatial organization of intra-tumour heterogeneity and evolutionary trajectories of metastases in hepatocellular carcinoma.
Zhai W; Lim TK; Zhang T; Phang ST; Tiang Z; Guan P; Ng MH; Lim JQ; Yao F; Li Z; Ng PY; Yan J; Goh BK; Chung AY; Choo SP; Khor CC; Soon WW; Sung KW; Foo RS; Chow PK
Nat Commun; 2017 Feb; 8():4565. PubMed ID: 28240289
[TBL] [Abstract][Full Text] [Related]
46. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
[TBL] [Abstract][Full Text] [Related]
48. ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma.
Zhou Z; Jiang H; Tu K; Yu W; Zhang J; Hu Z; Zhang H; Hao D; Huang P; Wang J; Wang A; Xiao Z; He C
J Exp Clin Cancer Res; 2019 Jan; 38(1):18. PubMed ID: 30646949
[TBL] [Abstract][Full Text] [Related]
49. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
[TBL] [Abstract][Full Text] [Related]
50. A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer.
Nam SJ; Yeo HY; Chang HJ; Kim BH; Hong EK; Park JW
Cancer Res Treat; 2016 Oct; 48(4):1229-1242. PubMed ID: 27034142
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition.
Zhou Y; Li Y; Ye J; Jiang R; Yan H; Yang X; Liu Q; Zhang J
Liver Int; 2013 Sep; 33(8):1271-80. PubMed ID: 23725476
[TBL] [Abstract][Full Text] [Related]
52. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
[TBL] [Abstract][Full Text] [Related]
53. CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma.
Huang D; Cao L; Zheng S
J Exp Clin Cancer Res; 2017 Jan; 36(1):13. PubMed ID: 28093067
[TBL] [Abstract][Full Text] [Related]
54. Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
Yamada S; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Ishikawa D; Shimada M
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S436-42. PubMed ID: 24566861
[TBL] [Abstract][Full Text] [Related]
55. Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinoma.
Lai JP; Conley A; Knudsen BS; Guindi M
Histopathology; 2015 Oct; 67(4):442-50. PubMed ID: 25425262
[TBL] [Abstract][Full Text] [Related]
56. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
Zhang Y; Fan Y; Mei Z
Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
[TBL] [Abstract][Full Text] [Related]
57. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
[TBL] [Abstract][Full Text] [Related]
58. Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity.
Shi JY; Xing Q; Duan M; Wang ZC; Yang LX; Zhao YJ; Wang XY; Liu Y; Deng M; Ding ZB; Ke AW; Zhou J; Fan J; Cao Y; Wang J; Xi R; Gao Q
Oncotarget; 2016 Jan; 7(3):2867-77. PubMed ID: 26672766
[TBL] [Abstract][Full Text] [Related]
59. Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors.
Kanda M; Tateishi R; Yoshida H; Sato T; Masuzaki R; Ohki T; Imamura J; Goto T; Yoshida H; Hamamura K; Obi S; Kanai F; Shiina S; Omata M
Liver Int; 2008 Nov; 28(9):1256-63. PubMed ID: 18710423
[TBL] [Abstract][Full Text] [Related]
60. The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer.
Ko E; Seo HW; Jung ES; Kim BH; Jung G
Oncotarget; 2016 Jan; 7(1):684-99. PubMed ID: 26575952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]